Locations:

Tag: aldosterone synthase inhibitor

March 31, 2025/Heart, Vascular and Thoracic/Preventive Cardiology

Lorundrostat Shows Continued Promise Against Uncontrolled Hypertension

Phase 2b trial of aldosterone synthase inhibitor also finds no benefit from dose escalation

Middle-aged overweight Hispanic woman having her blood pressure checked

September 11, 2023/Heart, Vascular and Thoracic/Preventive Cardiology

Lorundrostat Safely Lowers Blood Pressure in Uncontrolled Hypertension in Phase 2 Trial

Results inform dose selection for further trials of the aldosterone synthase inhibitor

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy